MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1020.73%
Quick Ratio
1020.73%
Unit: Dollar
Assets Breakdown
    • Cash
    • Property and equipment, net
    • Deferred offering costs, non-cur...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash
8,296,296
4,908,769
3,757,594
2,849,816
Prepaid expenses and other current assets
497,029
466,330
407,946
457,556
Total current assets
8,793,325
5,375,099
4,165,540
3,307,372
Property and equipment, net
81,929
119,927
196,521
241,082
Intangible assets, net
-
-
-
0
Deferred offering costs, non-current
68,745
26,438
-
-
Total other assets
150,674
146,365
196,521
241,082
Total assets
8,943,999
5,521,464
4,362,061
3,548,454
Total mezzanine equity
-
-
0
0
Due to related parties
-
-
0
-
Accounts payable
682,794
280,315
683,707
1,040,967
Due to related parties
26,750
-
-
99,875
Accrued expenses and other current liabilities
151,931
180,361
222,178
222,843
Total current liabilities
861,475
460,676
905,885
1,363,685
Common stock, 0.01 par value, 100,000,000 shares authorized, 3,935,884 and 1,061,533 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
39,358
18,875
5,183
30,260
Additional paid-in capital
128,145,545
122,108,934
116,684,259
113,506,692
Accumulated deficit
-119,507,698
-116,479,965
-112,652,321
-110,778,652
Accumulated other comprehensive loss
-594,681
-587,056
-580,945
-573,531
Total shareholders equity
8,082,524
5,060,788
3,456,176
2,184,769
Total liabilities, mezzanine equity, and shareholders equity
8,943,999
5,521,464
4,362,061
3,548,454
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$8,296,296 (191.12%↑ Y/Y)Prepaid expenses andother current assets$497,029 (8.63%↑ Y/Y)Property and equipment,net$81,929 (-66.02%↓ Y/Y)Deferred offering costs,non-current$68,745 Total current assets$8,793,325 (165.87%↑ Y/Y)Total other assets$150,674 (-37.50%↓ Y/Y)Total assets$8,943,999 (152.05%↑ Y/Y)Total liabilities,mezzanine equity, and...$8,943,999 (152.05%↑ Y/Y)Total shareholdersequity$8,082,524 (269.95%↑ Y/Y)Total currentliabilities$861,475 (-36.83%↓ Y/Y)Accumulated deficit-$119,507,698 (-7.88%↓ Y/Y)Accumulated othercomprehensive loss-$594,681 (-3.69%↓ Y/Y)Additional paid-in capital$128,145,545 (12.90%↑ Y/Y)Accounts payable$682,794 (-34.41%↓ Y/Y)Accrued expenses andother current...$151,931 (-31.82%↓ Y/Y)Due to relatedparties$26,750 (-73.22%↓ Y/Y)Common stock, 0.01 parvalue, 100,000,000...$39,358 (30.07%↑ Y/Y)

Enveric Biosciences, Inc. (ENVB)

Enveric Biosciences, Inc. (ENVB)